Skip to content
← Clinical Cases

Learning Lab Values & Drug Monitoring — clinical cases

29 questions

Sample cases

  1. Case 1

    A 61-year-old man (weight 82 kg, serum creatinine 88 µmol/L [1.0 mg/dL]) is started on IV vancomycin for MRSA bacteremia. According to the 2020 US consensus guideline on vancomycin monitoring (ASHP/IDSA/PIDS/SIDP), which monitoring strategy is recommended?

    • A.Target a trough of 15–20 mg/L, using the trough as the only measured concentration
    • B.Target an AUC24 of 400–600 mg·h/L, estimated by Bayesian software or from two measured concentrations
    • C.Target a peak of 30–40 mg/L measured 1 hour after the end of the first infusion
    • D.Target a trough of 10–15 mg/L and stop measuring once one result is in range
  2. Case 2

    A 55-year-old woman with MRSA osteomyelitis and stable renal function receives vancomycin 750 mg IV every 12 hours (1500 mg/day). Using two steady-state concentrations, her estimated AUC24 is 300 mg·h/L. Assuming linear pharmacokinetics, what total daily dose is predicted to give an AUC24 of 500 mg·h/L?

    • A.900 mg/day
    • B.1700 mg/day
    • C.2500 mg/day
    • D.1250 mg/day
  3. Case 3

    A 70-year-old man receives conventional (multiple-daily) gentamicin 120 mg IV every 8 hours in combination with a beta-lactam for gram-negative sepsis from a urinary source. At steady state his peak is 7.5 mg/L and his trough is 3.1 mg/L; serum creatinine has risen from 95 to 125 µmol/L (1.1 to 1.4 mg/dL). Which adjustment best addresses these results?

    • A.Keep the same dose and lengthen the dosing interval
    • B.Keep the same interval and increase each dose
    • C.Keep the same dose and shorten the dosing interval
    • D.Reduce each dose by 10% and keep the 8-hour interval